Restricted accessOtherFirst published online 2010-7
Comments on ‘The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia’
Abou El-Magd R., Park H., Kawazoe T., et al. (2009) The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia . J Psychopharmacol24: 1055-1067.
2.
Andreasen NC, Pierson R. ( 2008) The role of the cerebellum in schizophrenia. Biol Psychiat64: 81-88.
3.
Ferraris D., Duvall B., Ko YS, et al. (2008) Synthesis and biological evaluation of D-amino acid oxidase inhibitors. J Med Chem51: 3357-3359.
4.
Hashimoto K. ( 2008) CSF serine enantiomers and glycine in the study of neurologic and psychiatric disorders. Clin Chem54: 1413-1414.
5.
Hashimoto K., Fujita Y., Horio M., et al. (2009) Co-administration of a D-amino acid oxidase inhibitor potentiates the efficacy of D-serine in attenuating prepulse inhibition deficits after administration of dizocilpine. Biol Psychiat65: 1103-1106.
6.
Hashimoto K., Fukushima T., Shimizu E., et al. (2003) Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. Arch Gen Psychiat60: 572-576.
7.
Hashimoto K., Shimizu E., Iyo M. ( 2005) Dysfunction of glia-neuron communication in pathophysiology of schizophrenia. Curr Psychiat Rev1: 151-163.
8.
Katsetos CD, Hyde TM, Herman MM ( 1997) Neuropathology of the cerebellum in schizophrenia-an update: 1996 and future directions. Biol Psychiat42: 213-224.
9.
Morikawa A., Hamase K., Inoue T., Konno R., Niwa A., Zaitsu K. ( 2001) Determination of free D-aspartic acid, D-serine and D-alanine in the brain of mutant mice lacking D-amino acid oxidase activity. J Chrom B Biomed Sci Appl757: 119-125.
10.
Schell MJ ( 2004) The N-methyl-D-aspartate glycine site and D-serine metabolism: an evolutionary perspective. Philos T Roy Soc B359: 943-964.
11.
Tsai G., Yang P., Chung LC, Lange N., Coyle JT ( 1998) D-Serine added to antipsychotics for the treatment of schizophrenia. Biol Psychiat44: 1081-1089.
